By MATTHEW PERRONE 2010-07-15T04:26:10Z WASHINGTON (AP) -- GlaxoSmithKline's drug Avandia should stay on the market, federal health experts voted Wednesday, but the controversial diabetes pill should be subject to new restrictions due to risky heart side effects....